[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2931 Introduced in House (IH)]

  1st Session
                                H. R. 2931

 To provide for the expansion of human clinical trials qualifying for 
                        the orphan drug credit.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             July 25, 2003

    Mr. Brady of Texas (for himself and Mr. Matsui) introduced the 
 following bill; which was referred to the Committee on Ways and Means

_______________________________________________________________________

                                 A BILL


 
 To provide for the expansion of human clinical trials qualifying for 
                        the orphan drug credit.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Orphan Drug Tax Credit Act of 
2003''.

SEC. 2. EXPANSION OF HUMAN CLINICAL TRIALS QUALIFYING FOR ORPHAN DRUG 
              CREDIT.

    (a) In General.--Subclause (I) of section 45C(b)(2)(A)(ii) of the 
Internal Revenue Code of 1986 is amended to read as follows:
                                    ``(I) after the date that the 
                                application is filed for designation 
                                under such section 526, and''.
    (b) Conforming Amendment.--Clause (i) of section 45C(b)(2)(A) of 
such Code is amended by inserting ``which is'' before ``being'' and by 
inserting before the comma at the end ``and which is designated under 
section 526 of such Act''.
    (c) Effective Date.--The amendments made by this Act shall apply to 
amounts paid or incurred after the date of the enactment of this Act.
                                 <all>